Clearline Capital’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,295
Closed -$1.45M 140
2022
Q4
$1.45M Hold
11,295
0.26% 77
2022
Q3
$1.54M Buy
+11,295
New +$1.84M 0.18% 81

Other funds holding SGEN

Clearline Capital's SGEN Position: Q1 2023 in Review

Clearline Capital sold out of Seagen Inc. Common Stock (SGEN) in Q1 2023, closing a stake of 11,295 shares — an estimated $1.45M sold.

Clearline Capital first reported a position in SGEN in Q3 2022 and held it in 2 quarters. The position peaked at $1.54M in Q3 2022. 575 funds tracked by Wall St. Rank hold SGEN as of Q1 2023.

  • Clearline Capital reported no remaining Seagen Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Clearline Capital sold 11,295 Seagen Inc. Common Stock shares in Q1 2023, an estimated $1.45M.
  • Clearline Capital first reported a position in Seagen Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Clearline Capital's Seagen Inc. Common Stock position peaked at $1.54M in Q3 2022.
  • 575 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2023.

Based on Clearline Capital's 13F filing for Q1 2023, filed 15 May 2023.